Send us a text

Jim Foote explains why cancer treatment still relies on tradition more than biology, and how functional testing of a patient’s own tumor can change that.

We unpack his decision support approach that ranks drugs and combinations by sensitivity, the clinical evidence and validation behind it, and the practical realities of getting results into oncologists’ hands when time, toxicity, and payer rules all collide.

Connect with Jim on LinkedIn

Explore the First Ascend Biomedical Website

See More ChalkTalkJim Episodes

Send us a text

Bluebird Kids Health CEO Chris Johnson makes the economic and moral case for investing in pediatric primary care for Medicaid populations. Drawing parallels between caring for frail seniors and serving healthy children, he explains why predictable wellness visits, combined with proactive population health management, can transform community outcomes. Chris discusses locating clinics in pediatric care deserts, measuring success through net promoter scores rather than billing codes, and advocating for children's health in changing policy landscapes.

Bluebird Kids Health website.

Chris Johnson LinkedIn

See More ChalkTalkJim Episodes

Send us a text

What happens when people simply cannot afford to use the insurance they technically have? Gary Johnson from Qurate unpacks the quiet crisis of patient responsibility, rising deductibles, and expiring ACA subsidies. We explore how this crushes families, destabilizes hospital margins, and forces hard choices about who gets care and when, plus how better financial access models can change the trajectory.

See More ChalkTalkJim Episodes

Send us a text

Attorney and Phia Group CEO Adam Russo breaks down what it really takes for self-funded employers to “win” at healthcare.

He explains how to use claims data as a strategic asset, design more innovative benefit plans, avoid stop-loss landmines, and turn employees into engaged healthcare consumers.

Adam also shares practical incentive programs and direct primary care strategies that have delivered free healthcare and 97% retention in his own company.

LinkedIn

See More ChalkTalkJim Episodes

Send us a text

Julio Martinez Clark breaks down how Bio Access helps founders protect their burn rate while getting to first in human data faster. He explains why time to site activation matters more than line item budgets, how to think about patient recruitment in emerging markets, and what inexperienced PhD and physician founders usually overlook when they try to manage overseas trials without an expert clinical operations partner.

Podcast

LinkedIN

See More ChalkTalkJim Episodes

Send us a text

Obesity contributes more than $2 trillion to U.S. healthcare costs, but solutions remain fragmented. In this episode, Elina Onitskansky explains how aligning affordability, evidence-based medicine, and precision care can unlock massive value. We dive into her personal story, the systemic coding failures, and the importance of adherence and support. This conversation shows why obesity care is both a moral imperative and a business opportunity.

LinkedIn

See More ChalkTalkJim Episodes

Send us a text

Not all hospital tech is about medical records or patient charts. Allen Cooper takes us inside the world of environmental services, where clean rooms, infection control, and operational efficiency directly affect patient safety. Learn how his mobile platform equips frontline staff, streamlines facility management, and creates measurable quality gains while keeping costs in check.

LinkedIN

See More ChalkTalkJim Episodes

Send us a text

Jolly Nanda, founder of Althea, shares how her personal journey through decades of misdiagnosis inspired a mission to address the issues in healthcare data. From Medicare billing codes to wearable tech, she makes the case for individual health data ownership. She explains how the Acuvia platform is revolutionizing chronic disease care and interoperability by aligning incentives, not just systems.

LinkedIn Profile

See More ChalkTalkJim Episodes